FVFrancisco Jose Vasallo Vidal

Francisco Jose Vasallo Vidal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francisco Jose Vasallo Vidal has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Luminex® NxTAG® and Seegene Allplex™ Gastrointestinal Panels Using the Automated STARlet AIOS System from Stool Specimens

    by Ana De Malet, Iván Pensado-Mendez, Diego Solla-Medal, Eva Cerqueira-Gonzalez, Francisco J. Vasallo-Vidal, Carmen Potel

    Gastroenteritis remains a leading cause of morbidity worldwide. Although conventional stool culture and microscopy are considered the reference standards for diagnosis, they are time-consuming and their performance may be affected by prior antibiotic use. Molecular syndromic panels offer a rapid alternative for the simultaneous detection of a wide range of gastrointestinal pathogens. Objective: This study aimed to evaluate the diagnostic performance and clinical utility of two molecular syndromic panels, the Seegene Allplex™ Gastrointestinal Multiplex PCR Assay on the automated STARlet AIOS platform (SGN) and the Luminex NxTAG® Gastrointestinal Pathogen Panel (LMX), using stool specimens collected in Cary-Blair medium, compared with conventional diagnostic methods. Methods: A total of 124 stool specimens from patients with suspected gastrointestinal infection were analyzed. Diagnostic performance and inter-method agreement were assessed using Positive Percent Agreement (PPA), Negative Percent Agreement (NPA), and Cohen's kappa (κ), both before and after comparison with the reference standard (stool culture and microscopy). Results: Both molecular methods significantly increased pathogen detection, identifying 19 additional pathogens with SGN and 38 with LMX compared with the reference standard. Overall agreement between the two molecular assays was excellent (κ ≥ 0.80), although lower concordance was observed for Salmonella spp. (κ = 0.20) and Adenovirus (κ = 0.65). LMX showed 100% sensitivity for Salmonella spp. but generated a high number of unconfirmed positive results. Both platforms doubled the detection rate of Giardia lamblia compared with microscopy. Conclusion: Both molecular platforms are robust tools for the rapid detection of gastrointestinal pathogens, significantly improving diagnostic yield and supporting earlier clinical decision-making. However, unconfirmed positive results should be interpreted with caution and correlated with clinical findings. A combined diagnostic strategy, using rapid multiplex PCR screening alongside conventional methods, may provide the greatest clinical value by integrating rapid pathogen detection with antimicrobial susceptibility testing and the probability of epidemiological surveillance.

  • Open Access

    Influence of a microbiological commentary on the management of asymptomatic bacteriuria

    by Bitalio Jhon Montaño-Barrientos, María Teresa Pérez-Rodríguez, Sonia María Rey-Cao, Anniris María Rincón-Quintero, Jassiel Yáñez-Ledezma, Francisco José Vasallo-Vidal, Lucía Martínez-Lamas

    Introduction: The treatment of asymptomatic bacteriuria (AB) has been associated with increased in antibiotic resistance and Clostridioides difficile infection, without clinical benefit. One strategy to improve management is to incorporate a recommendation in the microbiological report. The aim of the study was to assess the impact of this intervention on antibiotic prescribing for AB. Methods: Potential cases of AB were identified, and the following comment was included in the microbiology report: “Assess according to clinical findings. In AB, no treatment is recommended”. Patient demographics, sample characteristics, reason for request, isolated microorganism, resistance profile, time to clinician’s review of the report, initiation of treatment and its causes, and repeat urine culture were collected. Factors associated with adherence to the recommendations were evaluated. Results: A total of 391 possible AB cases were identified. The majority of samples originated, from primary care (96%) and in women over 65 years of age (98%). Antibiotic treatment was initiated in 60% of cases, while the microbiological recommendation was followed in 40%. Factors associated with nonadherence to the recommendation included urine culture request prompted by foul-smelling or cloudy urine, and repeat culture. In contrast, urine cultures requested during routine health checks were more likely to be associate with adherence to the recommendation. Conclusions: The inclusion of a commentary in the microbiology report contributed to a reduction in antimicrobial prescription in AB. This intervention may be effective in optimising antibiotic prescribing practices and improving urine culture request management policies.

  • Open Access

    Oral amoxicillin/clavulanate for the prevention of bacteremia following dental extractions

    by Márcio Diniz Freitas, Maximiliano Álvarez Fernández, Francisco Jose Vasallo Vidal, Jacobo Limeres Posse, Pedro Diz Dios, Javier Fernández Feijoo

    This study aimed to evaluate the effectiveness of oral amoxicillin/clavulanate (AMX‐CL) for the prevention of bacteremia following dental extractions. The study group (AMX‐CLG) comprised 40 adults requiring dental extractions under general anesthesia who were administered a prophylactic regimen of 1875/125 mg of AMX‐CL orally 1–2 h prior to the surgery. Venous blood samples were collected from each patient at baseline and at 30 s and 15 min after dental extractions. Samples were inoculated into BACTEC Plus culture bottles and processed in the BACTEC 9240. Conventional microbiological techniques were used for subcultures and further identification of the isolated bacteria. The results for the AMX‐CLG were compared with those of a control group (CG; no prophylaxis) and an amoxicillin group (AMXG; 2 g of amoxicillin orally), consisting of randomly selected patients from among those participating in two clinical trials that we have previously published. The prevalence of bacteremia in the CG, AMXG, and AMX‐CLG was 97%, 50%, and 15%, respectively, at 30 s after completing the extractions, and 67%, 10%, and 4% at 15 min, respectively, after the last extraction. The prevalence of bacteremia in the AMXG and the AMX‐CLG at 30 s and at 15 min after completing the extractions was significantly lower than that in the CG (p < 0.001 and p < 0.001, respectively; Fisher’s exact test). The prevalence of bacteremia in the AMX‐CLG at 30 s after completing the extractions was significantly lower than that in the AMXG (p < 0.001; Fisher’s exact test). Based in the results of this preliminary study, oral AMX‐CL could be an excellent option for preventing bacteremia secondary to dental procedures in patients at risk.